Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Studies find no evidence that estrogens in soy increase uterine cancer risk

03.11.2005


Studies in monkeys and women suggest that unlike traditional estrogen therapy, a diet high in the natural plant estrogens found in soy does not increase the risk of uterine cancer in postmenopausal women, according to Mark Cline, D.V.M., Ph.D., an associate professor of comparative medicine at Wake Forest University Baptist Medical Center.



"These findings give us some confidence that dietary soy doesn’t promote uterine cancer and, in fact, may offer a protective effect in some cases," said Cline, who summarized the research studies today in Chicago at the 6th International Symposium on the Role of Soy in Preventing and Treating Chronic Disease.

Cline said there has been much debate about whether high levels of dietary soy are safe for postmenopausal women. Soy products are sometimes sold as a natural alternative to traditional estrogen therapy, which does increase the risk of endometrial cancer. The formulation of hormone therapy designed to address that risk – a combination of estrogen and progesterone –has been shown to increase risk of breast cancer.


Soy and some other plants contain estrogen-like compounds called isoflavones or phytoestrogens. These plant estrogens are thousands of times weaker than the estrogen produced by the body, but may be present in much higher concentrations in the blood. Researchers are not certain how plant estrogens and the estrogen produced by the body, or given in pills, act together. One theory is that the plant estrogens bind to cells that have estrogen receptors, such as breast and uterine tissue, and block the effects of the estrogen pills or estrogen made by the body.

Evidence about the safety of soy isoflavones has been mixed. It is known that populations that typically consume diets high in soy have much lower rates of uterine cancer. On the other hand, some laboratory studies in animals have shown that soy isoflavones can stimulate the growth of uterine cells, which is a marker for cancer risk.

Last year, researchers from Italy reported that six women who took soy tablets for up to five years had an increased occurrence of endometrial hyperplasia, a condition in which the lining of the uterus grows too much and may progress to cancer. The study involved 375 women – half took the soy pills and half took an inactive placebo tablet.

"This observation from this study and its interpretation should be carefully considered," said Cline. "Both human observational studies and several short-term trials of soy isoflavones have not shown any proliferation-inducing effect of soy isoflavones on the uterus."

Cline said that preliminary results from a two-year study of women who consumed 58 milligrams of soy isoflavones a day show no relationship between the soy and endometrial proliferation, and that investigators at other institutions have made similar findings. Similarly, Cline said, monkeys who received soy isoflavones at dietary doses for the equivalent of 10 human years did not show increased risk of endometrial hyperplasia. The monkeys ate one of three diets: soy that didn’t contain isoflavones, soy with the isoflavones intact, or soy without isoflavones, but with Premarin, or estrogen therapy, added.

The isoflavone group consumed the human equivalent of about 129 milligrams a day, more than most people would get in a soy-rich diet. The researchers measured numbers of dividing uterine cells and levels of the estrogen produced by the body – all markers for cancer risk. Monkeys on the soy plus estrogen diet had increased levels of all markers, while monkeys that ate soy with isoflavones did not.

In a short-term study, researchers gave monkeys 10 times the levels of isoflavones normally consumed through diet and again found no effects on the uterus.

Cline said that the results of these studies apply to dietary soy – and not to the high levels of isoflavones found in soy pills. He also noted that the studies cannot completely rule out the potential for risk. However, he concludes that "the bulk of the experimental evidence points to a protective effect of soy consumption on endometrial cancer risk."

Karen Richardson | EurekAlert!
Further information:
http://www.wfubmc.edu

More articles from Studies and Analyses:

nachricht Smart Data Transformation – Surfing the Big Wave
02.12.2016 | Fraunhofer-Institut für Angewandte Informationstechnik FIT

nachricht Climate change could outpace EPA Lake Champlain protections
18.11.2016 | University of Vermont

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Simple processing technique could cut cost of organic PV and wearable electronics

06.12.2016 | Materials Sciences

3-D printed kidney phantoms aid nuclear medicine dosing calibration

06.12.2016 | Medical Engineering

Robot on demand: Mobile machining of aircraft components with high precision

06.12.2016 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>